Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The weekend factor: the effect on healthcare quality. A medico-legal, retrospective study.

La Clinica terapeutica·2024
Same author

Influence of age on force and re-lengthening dynamics after tetanic stimulation withdrawal in the tibialis anterior muscle.

European journal of applied physiology·2023
Same author

Sex-related differences and chronobiology of ST-elevation myocardial infarction: findings from a single hub center in Italy.

European review for medical and pharmacological sciences·2023
Same author

Wastewater analysis and drug consumption: useful assessment tool.

La Clinica terapeutica·2022
Same author

Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel.

AIDS and behavior·2022
Same author

The evolution of European legislation on doping: new challenges in the age of NPS.

European review for medical and pharmacological sciences·2022

Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.8K

Estimating HCV disease burden-volume 4 (editorial).

G J Dore1, A Hatzakis2, F Negro3

  • 1Kirby Institute, University of New South Wales, Sydney, NSW, Australia.

Journal of Viral Hepatitis
|November 7, 2017
PubMed
Summary

Hepatitis C virus (HCV) affects 71 million globally. New direct-acting antiviral (DAA) therapies offer a highly effective, short-term treatment option to combat the growing burden of HCV infection and its complications.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge, impacting millions worldwide.
Keywords:
diagnosisdisease burdenepidemiologyhepatitis Chepatitis C virusprevalencestrategysustained viral responsetherapiestotal infectionstreatment

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.3K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K

Related Experiment Videos

Last Updated: Feb 19, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.8K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.3K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K
  • HCV infection leads to severe liver conditions like cirrhosis and hepatocellular carcinoma (HCC), increasing mortality.
  • Existing data on HCV epidemiology and disease burden are often fragmented across diverse regions.